SLN NASDAQ
Silence Therapeutics plc
1W: -4.8%
1M: -28.1%
3M: +0.6%
YTD: +73.0%
1Y: +108.6%
3Y: +9.7%
5Y: -51.2%
$10.64
-0.07 (-0.65%)
Weekly Expected Move ±5.2%
$10
$10
$11
$11
$12
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$1M
Revenue
-97.6% YoY
$-60M
Net Income
+12.8% YoY
$-42M
Free Cash Flow
+46.2% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-90.4%
ROA-44.1%
ROIC157.8%
Valuation
P/E-2.8
P/B4.4
EV/EBITDA-1.7
Leverage
Debt/Equity0.00
Current Ratio7.42
Interest Cov.0.0x
Quality Scores
Piotroski F1/9
Altman Z-7.19
Beneish M0.00